Larotrectinib and Idelalisib: Interaction Details
- Idelalisib
- Zydelig
- Larotrectinib
- VitrakviIVitrakvi
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Larotrectinib and Idelalisib interaction:
Larotrectinib
- VitrakviI
- Vitrakvi
What Happens When You Take Larotrectinib With Idelalisib
What can happen when they are taken together (rated Major)
Increased larotrectinib exposure
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Larotrectinib is a , so it should not be used together with a strong CYP3A4 , because the inhibitor may raise larotrectinib exposure and thereby increase the likelihood of adverse reactions. When a single 100 mg dose of larotrectinib was given with itraconazole, a strong inhibitor, both the (0 to infinity) and the of larotrectinib rose.
If the combination is unavoidable, the larotrectinib dose should be lowered by 50%. Once the strong CYP3A4 inhibitor has been stopped for a period of 3 to 5 half-lives, the larotrectinib dose used before the inhibitor was started should be resumed.1
The Larotrectinib and Idelalisib Interaction, Explained
Idelalisib can raise the amount of larotrectinib in your body. Your body uses an enzyme called to break down larotrectinib, and idelalisib slows that enzyme down. With more larotrectinib around, side effects such as tiredness, dizziness, nausea, or changes in liver tests may become more likely.
This is based mainly on how the drugs are known to work, and on a study using a similar enzyme blocker. Doctors usually try to avoid this combination. If you need both, your care team can lower the larotrectinib dose and watch you more closely. Please don't change any doses on your own. Check with your pharmacist or doctor.
Mechanism: Idelalisib is a strong . Larotrectinib is a CYP3A4 , so decreases its and increases exposure (higher and ). Neither drug's activity depends on the affected enzyme for activation, so the direction is increased larotrectinib effect and toxicity.
- Evidence: theoretical for idelalisib specifically. Supportive data: itraconazole (strong inhibitor) increased larotrectinib AUC(0-inf) and Cmax after a single 100 mg dose.
- Onset: unspecified.
- Management: avoid combination. If unavoidable, reduce larotrectinib dose by 50%. After stopping the inhibitor, wait 3 to 5 half-lives, then resume the prior larotrectinib dose. Monitor for adverse reactions (e.g., , ).
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Larotrectinib and Idelalisib Interact
The likely mechanism
of -mediated of larotrectinib
How to Manage the Larotrectinib and Idelalisib Interaction
Care teams usually try to avoid using these two medicines together. If both are truly needed, the larotrectinib dose is typically reduced by 50% while idelalisib is being taken.
- Keep taking both exactly as prescribed unless your prescriber tells you otherwise.
- Tell your pharmacist and doctor about every medicine and supplement you use.
- Report new or worsening side effects promptly.
- If idelalisib is stopped, your team will advise when to return to your usual larotrectinib dose (after 3 to 5 half-lives of idelalisib).
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Larotrectinib or Idelalisib need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
1 report from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Prescribing information: VITRAKVI oral capsules, oral solution, larotrectinib oral capsules, oral solution
When a single 100 mg dose of larotrectinib was given together with itraconazole, a strong , larotrectinib (0 to infinity) rose 4.3-fold and rose 2.8-fold relative to larotrectinib given alone.1
Larotrectinib and Idelalisib: Common Questions
How serious is the Larotrectinib and Idelalisib interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Larotrectinib and Idelalisib interaction managed?
Care teams usually try to avoid using these two medicines together. If both are truly needed, the larotrectinib dose is typically reduced by 50% while idelalisib is being taken. Keep taking both exactly as prescribed unless your prescriber tells you otherwise. Tell your pharmacist and doctor about every medicine and supplement you use. Report new or worsening side effects promptly. If idelalisib i… Management is individual — always follow your own care team's guidance.
Does taking Larotrectinib and Idelalisib at different times of day help?
No. Taking them at different times of day does not prevent this one. Idelalisib slows , an enzyme that breaks down larotrectinib, so larotrectinib can build up in the body. That change lasts while idelalisib is being taken and can continue for a while after the last dose.
Your pharmacist or prescriber can tell you how they will manage it.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Larotrectinib and Idelalisib Interaction
Ask in your own words about taking Larotrectinib and Idelalisib together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: VITRAKVI(R) oral capsules, oral solution, larotrectinib oral capsules, oral solution. Bayer HealthCare Pharmaceuticals Inc (per FDA), Whippany, NJ, 2022. DailyMed
Other Serious Interactions of Larotrectinib and Idelalisib
Also serious with Idelalisib
- ColchicineContraindicated
- SimvastatinContraindicated
- AlfuzosinContraindicated
- Dihydroergotamine InjectionContraindicated
Also serious with Larotrectinib
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Idelalisib
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- Vitamin EModerate
- GingerModerate
- TurmericModerate
- Black PepperModerate
- GrapeModerate
- + 140 more
With Larotrectinib
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- Vitamin EModerate
- GingerModerate
- TurmericModerate
- Black PepperModerate
- GrapeModerate
- + 140 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.